SAMI.ai launches to enhance healthcare B2B sales success
SalesSparx and Augment have jointly launched SAMI.ai, a groundbreaking AI sales performance system designed to infuse over 10,000 hours of healthcare sales expertise into every sales conversation. The new tool aims to enhance the predictability and success of sales deals in the healthcare industry, a sector known for its complex and lengthy sales cycles.
Healthcare B2B sales teams face the challenge of managing multiple stakeholders and lengthy decision-making processes, which can easily lead to missed questions and hidden risks. SAMI.ai addresses these issues by embedding a decade of proven healthcare sales expertise into every sales interaction. The platform combines Augment's AI-native workflow orchestration with SalesSparx's proprietary knowledge, providing real-time guidance and identifying potential deal risks.
"SAMI.ai is a significant step forward in transforming how healthcare B2B sales are conducted," said Reese Gomez, CEO of SalesSparx. "By leveraging the intelligence of 10,000+ hours of proven sales expertise, we can help teams close more deals and reduce risk, ensuring that sales motions are more consistent and less reliant on the individual experience of a few key sellers."
The SAMI Knowledge Engine, powered by Augment, ensures that this expertise is applied consistently across all sales conversations. It assesses deal progress, identifies gaps in execution, and suggests the most effective actions to move opportunities forward. This system carries context from one interaction to the next, providing reps with tailored guidance and enabling leaders to track and intervene early in potential deal risks.
"SAMI.ai stands out because it brings the depth of healthcare sales expertise directly to the point of sale," said Andrew Fritts, CEO of Augment. "By integrating this intelligence into the workflows teams already use, we can help organizations achieve more consistent and successful sales outcomes."
SalesSparx is offering a no-cost deal review to healthcare software, technology, and services companies with revenues between $5 million and $100 million. Using SAMI.ai, the company will analyze active opportunities, pinpoint execution gaps, and recommend specific actions to help move deals forward. This service can be particularly valuable for companies seeking to optimize their sales processes and improve their chances of success.
"SAMI.ai is not just another tool; it's a comprehensive solution that can transform the way healthcare B2B sales are conducted," Gomez emphasized. "With SAMI.ai, we can help companies achieve more predictable revenue growth and reduce the reliance on heroic sales performance."
Healthcare B2B sales can be challenging due to the complexity of decision-making and the involvement of multiple stakeholders. SAMI.ai aims to simplify this process by providing real-time, expert-driven insights and guidance, ultimately leading to more successful sales outcomes.